Medical Devices Australia

Australia Breath Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia Breath Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Application, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $12.5 Mn Placeholder estimate
Estimate 2025 $14.2 Mn 1.3% of the global market
Projected 2034 $44.3 Mn 212.6% Adds $30.1 Mn over 9 forecast years
CAGR 2025–2034 13.5% Faster than 73% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Australia is 1.26% of the global market.
  • In APAC, the largest is China at $102.9 Mn.
  • Fastest growing: India at 14.9% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$30.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Breath Diagnostics Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $12.5 Mn — —
2025 (base) $14.2 Mn +$1.7 Mn —
2026 (forecast) $16.1 Mn +$1.9 Mn +13.5%
2027 (forecast) $18.3 Mn +$2.2 Mn +28.8%
2028 (forecast) $20.7 Mn +$2.5 Mn +46.2%
2029 (forecast) $23.5 Mn +$2.8 Mn +66%
2030 (forecast) $26.7 Mn +$3.2 Mn +88.4%
2031 (forecast) $30.3 Mn +$3.6 Mn +113.8%
2032 (forecast) $34.4 Mn +$4.1 Mn +142.6%
2033 (forecast) $39.0 Mn +$4.6 Mn +175.4%
2034 (forecast) $44.3 Mn +$5.3 Mn +212.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.13 Bn
  2. North America $624.6 Mn
  3. US $412.6 Mn
  4. APAC $252.6 Mn
  5. Europe $232.2 Mn
  6. China $102.9 Mn
  7. Canada $76.9 Mn
  8. Japan $62.8 Mn
  9. Latin America $52.8 Mn
  10. Middle East $48.6 Mn
  11. Germany $39.7 Mn
  12. Brazil $30.6 Mn
  13. UK $26.9 Mn
  14. France $26.4 Mn
  15. Italy $24.1 Mn
  16. Ecuador $24.0 Mn
  17. India $23.2 Mn
  18. Mexico $19.4 Mn
  19. Spain $18.9 Mn
  20. Saudi Arabia $19.2 Mn
  21. Africa $15.2 Mn
  22. Australia (this report) $14.2 Mn
  23. Russia $10.7 Mn
  24. New Zealand $10.1 Mn
  25. South Africa $8.5 Mn
  26. UAE $5.1 Mn
  27. Egypt $2.8 Mn
  28. Philippines $2.8 Mn
  29. Malaysia $2.0 Mn
  30. Hong Kong $1.8 Mn
  31. Singapore $1.5 Mn
  32. Thailand $1.5 Mn
  33. Kenya $0.9 Mn

Report snapshot

Australia Breath Diagnostics Market Analysis at a glance
Market size, 2025$14.2 Mn placeholder estimate
Forecast, 2034$44.3 Mn placeholder estimate
Growth (CAGR), 2025–203413.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, technology and end user (see all)
Key playersOwlstone Medical, Circassia (NIOX), Exalenz Bioscience, Kibion, Breathtec Biomedical (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Breath Diagnostics Market Analysis Executive Summary

Breath diagnostics analyse molecules in exhaled breath to detect diseases such as H. pylori infection, asthma and some cancers.

Key segments of the breath Diagnostics market include application (H. pylori Testing, Asthma (FeNO) and Gut Disorders) and technology (Urea Breath Tests, FeNO Analyzers and Mass Spectrometry).

Bar chart: Australia Breath Diagnostics market size, 2024–2034, placeholder estimates. $12.5 Mn in 2024, $14.2 Mn in 2025 and $44.3 Mn in 2034, 13.5% CAGR.
Australia Breath Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Breath Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the breath Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the breath Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the breath Diagnostics market.

Competitive Landscape for Breath Diagnostics Market in Australia

The breath Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Breath Diagnostics Market in Australia

Breath Diagnostics in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how breath Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Breath Diagnostics right now, from free public sources.

Latest research 11,191 papers since 2021 (worldwide)

  1. GLP-1 dose escalation and disputed ignition interlock alcohol results: Case report. The Medico-legal journal, 2026
  2. Scrub typhus masquerading as an acute appendicitis: a case report. Annals of medicine and surgery (2012), 2026
  3. Dismissed for drinking without drinking: confirmed auto-brewery syndrome in a law-enforcement officer - a case report. Annals of medicine and surgery (2012), 2026
  4. Sex differences in central adiposity, hemodynamic, and respiratory parameters among healthy young Nigerian adults: a cross-sectional study. Frontiers in physiology, 2026
  5. From Phenotypes to Metabolotypes: Redefining Small Intestinal Overgrowth Syndromes through the Lens of Microbial Metabolic Signaling and Durable Disease Management. Biomedical journal, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Breath Diagnostics in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Breath Diagnostics market in Australia?
Placeholder estimate: about $14.2 Mn in 2025, rising to about $44.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Breath Diagnostics market in Australia growing?
Placeholder estimate: about 13.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Breath Diagnostics market report cover?
The report splits the market by application (H. pylori Testing, Asthma (FeNO), Gut Disorders, Cancer Detection), technology (Urea Breath Tests, FeNO Analyzers, Mass Spectrometry, Electronic Nose) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Breath Diagnostics market?
Key players include Owlstone Medical, Circassia (NIOX), Exalenz Bioscience, Kibion and Breathtec Biomedical.
What is driving the Breath Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the breath Diagnostics market.
Who regulates Breath Diagnostics in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on Breath Diagnostics?
PubMed lists 11,191 papers on Breath Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Breath Diagnostics in Australia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Prebiotics: Feeding the Good BacteriaMore than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful… Gut Health and Probiotics: What the Science SaysGut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Australia

See all
Same topic, other categories

Related on diagnostics and lab testing and respiratory

See the topic